Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Th17 Immune Response in Patients With COVID-19 and Nonalcoholic Fatty Liver Disease

NCT04982328 is registered in ClinicalTrials.gov with University Hospital for Infectious Diseases, Croatia as lead sponsor.

NCT NCT04982328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04982328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Th17 Immune Response in Patients With COVID-19 and Nonalcoholic Fatty Liver Disease
Lead sponsor
University Hospital for Infectious Diseases, Croatia
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
December 15, 2022
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, nafld